TCRαβ KO CD8+ NFAT-Luc Jurkat
CBP74520
詢 價
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| N/A | |
| II. Description | |
| TCRαβ KO CD8+ NFAT-Luc Jurkat 細胞,在 NFAT-Luc Jurkat 細胞上敲除 TCRαβ,表達CD8。 | |
| III. Introduction | |
| 敲除基因: | TCRαβ |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+800 μg/ml Hygromycin B +1 μg/ml Puromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Representative Data | |
![]() Figure 1. TCRαβ KO CD8+ NFAT-Luc Jurkat 細胞,在 NFAT-Luc Jurkat 細胞上敲除 TCRαβ,表達CD8。 ![]() Figure 2. Dose Response of CD3 Agonist Antibody in TCRαβ KO CD8+ NFAT-Luc Jurkat(C57). |
|

